Prelude Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
493
+137
| +38% | +$71.9K | 0.03% | 677 |
|
|
2025
Q1 | $226K | Buy |
+356
| New | +$226K | 0.02% | 774 |
|
|
2024
Q4 | – | Sell |
-582
| Closed | -$612K | – | 1376 |
|
|
2024
Q3 | $612K | Buy |
+582
| New | +$612K | 0.04% | 475 |
|
|
2023
Q3 | – | Sell |
-692
| Closed | -$497K | – | 1184 |
|
|
2023
Q2 | $497K | Buy |
692
+201
| +41% | +$144K | 0.03% | 394 |
|
|
2023
Q1 | $403K | Buy |
+491
| New | +$403K | 0.02% | 467 |
|
|
2022
Q1 | – | Sell |
-1,145
| Closed | -$723K | – | 1829 |
|
|
2021
Q4 | $723K | Buy |
1,145
+323
| +39% | +$204K | 0.02% | 607 |
|
|
2021
Q3 | $497K | Sell |
822
-1,164
| -59% | -$704K | 0.01% | 672 |
|
|
2021
Q2 | $1.11M | Buy |
+1,986
| New | +$1.11M | 0.03% | 425 |
|
|
2021
Q1 | – | Sell |
-1,136
| Closed | -$549K | – | 1330 |
|
|
2020
Q4 | $549K | Buy |
1,136
+257
| +29% | +$124K | 0.01% | 352 |
|
|
2020
Q3 | $492K | Sell |
879
-390
| -31% | -$218K | 0.02% | 295 |
|
|
2020
Q2 | $791K | Buy |
1,269
+1,131
| +820% | +$705K | 0.04% | 199 |
|
|
2020
Q1 | $67K | Sell |
138
-2,229
| -94% | -$1.08M | ﹤0.01% | 430 |
|
|
2019
Q4 | $889K | Buy |
2,367
+2,320
| +4,936% | +$871K | 0.03% | 215 |
|
|
2019
Q3 | $13K | Sell |
47
-2,028
| -98% | -$561K | ﹤0.01% | 989 |
|
|
2019
Q2 | $649K | Buy |
2,075
+1,543
| +290% | +$483K | 0.03% | 238 |
|
|
2019
Q1 | $218K | Sell |
532
-1,201
| -69% | -$492K | 0.01% | 428 |
|
|
2018
Q4 | $647K | Sell |
1,733
-428
| -20% | -$160K | 0.04% | 246 |
|
|
2018
Q3 | $873K | Buy |
2,161
+333
| +18% | +$135K | 0.05% | 252 |
|
|
2018
Q2 | $631K | Buy |
+1,828
| New | +$631K | 0.04% | 352 |
|
|
2017
Q4 | – | Sell |
-1,618
| Closed | -$723K | – | 1506 |
|
|
2017
Q3 | $723K | Buy |
1,618
+995
| +160% | +$445K | 0.07% | 263 |
|
|
2017
Q2 | $306K | Buy |
623
+114
| +22% | +$56K | 0.03% | 403 |
|
|
2017
Q1 | $197K | Buy |
+509
| New | +$197K | 0.02% | 526 |
|
|
2016
Q1 | – | Sell |
-963
| Closed | -$523K | – | 1400 |
|
|
2015
Q4 | $523K | Sell |
963
-498
| -34% | -$270K | 0.08% | 235 |
|
|
2015
Q3 | $680K | Sell |
1,461
-210
| -13% | -$97.7K | 0.1% | 205 |
|
|
2015
Q2 | $852K | Sell |
1,671
-60
| -3% | -$30.6K | 0.12% | 192 |
|
|
2015
Q1 | $782K | Buy |
1,731
+961
| +125% | +$434K | 0.11% | 223 |
|
|
2014
Q4 | $316K | Sell |
770
-273
| -26% | -$112K | 0.05% | 452 |
|
|
2014
Q3 | $376K | Buy |
1,043
+232
| +29% | +$83.6K | 0.05% | 433 |
|
|
2014
Q2 | $229K | Sell |
811
-1,059
| -57% | -$299K | 0.03% | 600 |
|
|
2014
Q1 | $562K | Sell |
1,870
-342
| -15% | -$103K | 0.08% | 304 |
|
|
2013
Q4 | $609K | Hold |
2,212
| – | – | 0.1% | 256 |
|
|
2013
Q3 | $692K | Sell |
2,212
-2,972
| -57% | -$930K | 0.11% | 186 |
|
|
2013
Q2 | $1.17M | Buy |
+5,184
| New | +$1.17M | 0.25% | 67 |
|